- Home
- ATGL vs ALEC Comparison
ATGL vs ALEC Comparison
Compare ATGL & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATGL | ALEC |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 241.3M | 275.8M |
| IPO Year | 2023 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ATGL | ALEC |
|---|---|---|
| Price | $5.30 | $1.87 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $3.10 |
| AVG Volume (30 Days) | 7.9K | ★ 1.3M |
| Earning Date | 01-27-2027 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $21,045,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $155.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.52 | $1.09 |
| 52 Week High | $50.00 | $3.40 |
Technical Indicators
Market Signals| Indicator | ATGL | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 39.38 |
| Support Level | $4.52 | $1.77 |
| Resistance Level | $7.55 | $2.10 |
| Average True Range (ATR) | 0.61 | 0.12 |
| MACD | 0.14 | -0.03 |
| Stochastic Oscillator | 33.58 | 6.90 |
Price Performance
Historical ComparisonAbout ATGL Alpha Technology Group Limited
Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.